Home » Authors » Mark Lawson

Articles by Mark Lawson

Court Documents Reveal GSK's Stand On Relenza

June 15, 2005

Court Documents Reveal GSK's Stand On Relenza

June 15, 2005

Investor Interest Wanes For Australia's Biotech Stocks

April 20, 2005

Investor Interest Wanes For Australia's Biotech Stocks

April 20, 2005

Australian Stock Exchange: Commissioned Reports OK

Feb. 9, 2005

Australian Stock Exchange: Commissioned Reports OK

Feb. 9, 2005

Metabolic Jumps, Slides On Trial Data, Analyst Criticism

Dec. 22, 2004

Metabolic Jumps, Slides On Trial Data, Analyst Criticism

Dec. 22, 2004

Peptech, J&J Unit Centocor Settle Remicade IP Dispute

Nov. 24, 2004

Peptech, J&J Unit Centocor Settle Remicade IP Dispute

Nov. 24, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 22, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 21, 2024.
J&J’s Ottava robotic system approved for US pivotal trial
BioWorld MedTech
Johnson & Johnson received U.S. FDA investigational device exemption to begin the pivotal clinical trial for the Ottava robotic surgical system. If the trial goes...
‘Evo’ AI can design complete genomes
BioWorld Science
The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...
Medtronic receives CE mark for next generation Endoflip system
BioWorld MedTech
Medtronic plc obtained a CE mark for its next generation Endoflip 300 system which measures pressure and dimensions in the esophagus and pylorus, in adults. The...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.